{"gao_id": "GAO-03-177", "published": "2002-10-28T13:00:00Z", "released": "2002-12-04T08:00:00Z", "summary": "", "title": "Prescription Drugs: FDA Oversight of Direct-to-Consumer Advertising Has Limitations", "topics": ["Advertising", "Regulatory agencies", "Sales promotion", "Pharmaceutical industry", "Research and development", "Marketing", "Drugs", "Physicians", "Prescription drugs", "Surveys", "Health Care"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-03-177", "versions": [{"title": "Full Report (37 pages)", "url": "https://www.gao.gov/assets/gao-03-177.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/a236205.html"}]}